CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | Matsuda Masaru SVP, General Counsel | Exercise or conversion · Restricted Stock | −4,129 | 8,258 | ||
| 2021-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +7,883 | 135,911 | ||
| 2021-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −2,725 | $49.84 | $136K | 133,186 |
| 2021-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −7,883 | 15,766 | ||
| 2021-02-12 | Torley Helen President and CEO | Exercise or conversion | +32,795 | 519,090 | ||
| 2021-02-12 | Torley Helen President and CEO | Shares withheld for taxes | −16,259 | $49.84 | $810K | 502,831 |
| 2021-02-12 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −32,795 | 65,589 | ||
| 2021-02-10 | Matsuda Masaru SVP, General Counsel | Exercise or conversion | +6,257 | 17,699 | ||
| 2021-02-10 | Matsuda Masaru SVP, General Counsel | Shares withheld for taxes | −3,203 | $50.60 | $162K | 14,496 |
| 2021-02-10 | Matsuda Masaru SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −6,257 | 18,769 | ||
| 2021-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +8,134 | 130,934 | ||
| 2021-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −2,906 | $50.60 | $147K | 128,028 |
| 2021-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −8,134 | 24,399 | ||
| 2021-02-10 | Torley Helen President and CEO | Exercise or conversion | +31,282 | 501,804 | ||
| 2021-02-10 | Torley Helen President and CEO | Shares withheld for taxes | −15,509 | $50.60 | $785K | 486,295 |
| 2021-02-10 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −31,282 | 93,844 | ||
| 2021-02-01 | Kelley Kenneth J Director | Sale | −4,754 | $48.09 | $229K | 190,079 |
| 2021-02-01 | Kelley Kenneth J Director | Sale | −246 | $48.69 | $12K | 189,833 |
| 2021-02-01 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 520,522 |
| 2021-02-01 | Torley Helen President and CEO | Sale | −44,563 | $47.76 | $2.1M | 475,959 |
Page 53 of 59 · 1,177 trades